DDIT4 and ovarian carcinoma: The significant REDD1 up-regulation is found in bladder urothelial carcinoma, oral squamous cell carcinoma, ovarian cancer, myeloid leukemia, and glioblastoma multiform and is associated with poor outcomes [8,54,55,56].